CUA Speaker Tour: Theragnostics (Next generation PSMA theragnostics: What is coming next?)
DÉTAILS DE L’ACTIVITÉ
SESSION #3: Next generation PSMA theragnostics: What is coming next?
Professor Michael Hofman, MBBS, FRACP, FAANMS, FICIS
PET Modality Lead, Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging
Director, Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC)
Peter MacCallum Cancer Centre, Melbourne, Australia
Sir Peter MacCallum Department of Oncology, The University of Melbourne